Department of Radiation Oncology, Massachusetts General Hospital, Boston, United States of America.
Department of Radiation Oncology, Harvard Medical School, Boston, United States of America.
Phys Med Biol. 2024 Aug 6;69(16). doi: 10.1088/1361-6560/ad64b6.
. To allow the estimation of secondary cancer risks from radiation therapy treatment plans in a comprehensive and user-friendly Monte Carlo (MC) framework.. Patient planning computed tomography scans were extended superior-inferior using the International Commission on Radiological Protection's Publication 145 computational mesh phantoms and skeletal matching. Dose distributions were calculated with the TOPAS MC system using novel mesh capabilities and the digital imaging and communications in medicine radiotherapy extension interface. Finally, in-field and out-of-field cancer risk was calculated using both sarcoma and carcinoma risk models with two alternative parameter sets.. The TOPAS MC framework was extended to facilitate epidemiological studies on radiation-induced cancer risk. The framework is efficient and allows automated analysis of large datasets. Out-of-field organ dose was small compared to in-field dose, but the risk estimates indicate a non-negligible contribution to the total radiation induced cancer risk.. This work equips the TOPAS MC system with anatomical extension, mesh geometry, and cancer risk model capabilities that make state-of-the-art out-of-field dose calculation and risk estimation accessible to a large pool of users. Furthermore, these capabilities will facilitate further refinement of risk models and sensitivity analysis of patient specific treatment options.
. 为了在全面且用户友好的蒙特卡罗 (MC) 框架中估算放射治疗计划的继发癌症风险。.. 使用国际辐射防护委员会出版物 145 计算网格体模和骨骼匹配,将患者计划 CT 扫描向上和向下扩展。使用 TOPAS MC 系统的新型网格功能和数字成像和通信在医学放射治疗扩展接口中计算剂量分布。最后,使用肉瘤和癌风险模型以及两种替代参数集计算场内和场外癌症风险。.. TOPAS MC 框架得到扩展,以促进关于放射性癌症风险的流行病学研究。该框架效率高,允许对大型数据集进行自动分析。与场内剂量相比,场外器官剂量较小,但风险估计表明其对总放射性诱导癌症风险有不可忽视的贡献。.. 这项工作为 TOPAS MC 系统配备了解剖扩展、网格几何和癌症风险模型功能,使最先进的场外剂量计算和风险估计能够为大量用户所使用。此外,这些功能将有助于进一步完善风险模型和对患者特定治疗方案的敏感性分析。